Displaying 1 publication

Abstract:
Sort:
  1. Tepotinib Plus an EGFR Tyrosine Kinase Inhibitor in Patients With EGFR-Mutant MET-Altered NSCLC: A Case Series
    Le X, Eisert A, Hsia TC, Raut NV, Ahmad A, Chan OSH, et al.
    Clin Lung Cancer, 2025 Feb 21.
    PMID: 40140342 DOI: 10.1016/j.cllc.2025.02.013
Related Terms
    Try searching for something
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links